Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K023390
    Manufacturer
    Date Cleared
    2002-11-26

    (48 days)

    Product Code
    Regulation Number
    892.1940
    Reference & Predicate Devices
    Why did this record match?
    Product Code :

    IXH

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    My Breast Friend Breast Self-exam Pad is indicated as an aid for performing breast selfexamination.

    Device Description

    The My Breast Friend Breast Self-exam Pad is a thin polyurethane bladder containing a small quantity of silicone and air fluids. The very thin nature of the material allows the pad to conform to the patient's breast tissue and for the patient to observe a reduction in friction. The very thin and flexible bladder provides easy sliding between the upper and lower surfaces of the bladder and allows the patient to sense subtle tissue density variations.

    AI/ML Overview

    The provided text is related to a 510(k) submission for the "My Breast Friend Breast Self-exam Pad." The submission focuses on establishing substantial equivalence to previously marketed devices rather than presenting novel performance studies and acceptance criteria as would be required for new device approvals.

    Therefore, the document does not contain details about specific acceptance criteria, a study proving the device meets those criteria, or the other requested information such as sample sizes, expert qualifications, or ground truth establishment.

    Instead, the submission states:

    • Performance Standard: "No mandatory or voluntary standards are applicable."
    • Substantial Equivalence: "The My Breast Friend Self-exam Pad is substantially equivalent to the currently marketed devices, Sensor Pad (K973450) and Aware Pad (K991469)."

    The FDA's letter confirms their review and determination of substantial equivalence based on the indications for use. This pathway implies that the new device's safety and effectiveness are considered equivalent to a legally marketed predicate device, and thus, extensive new clinical performance data demonstrating specific acceptance criteria are not typically required in the same way as for a PMA or novel device.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1